For the active substances cyprodinil, formetanate, fosetyl, halosulfuron-methyl, phenmedipham, pirimicarb, spinosad, Trichoderma harzianum Rifai strains T-22 and ITEM 908, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T-25 and TV-1, Trichoderma atroviride (formerly T. harzianum) strain T11 and Trichoderma gamsii (formerly T. viride) strain ICC080, as the Authority needs additional time to reach a conclusion on the risk assessment, and in light of the remaining steps to be completed in each renewal procedure, the extension of the approval period for each of these active substances should be set at 19 months and 2 weeks.
Recital 35, Regulation (EU) 2025/99
In forcesince 21 Jan 2025